A novel integrated practice unit approach to peri-ocular skin cancer management

L. Y. Goh,C. Downie,A. M. S. Morley
DOI: https://doi.org/10.1038/s41433-024-02974-w
IF: 4.4563
2024-02-14
Eye
Abstract:Low infection rates of non-ophthalmic reconstructions already undertaken at the unit were reassuring, and the use of surgical loupes obviated the need for a microscope. Additional nurse training was provided, and occasional patients requiring or requesting general anaesthetic had alternative arrangements made. A formal audit of the service was conducted from 2020-2022, with results summarised in Table 1. The IPU group showed lower surgical complications and revision surgery rates ( p < 0.05), despite the higher relative proportion of recurrent lesions presenting during the pandemic. However, the lower proportion of diabetics and smokers coming for surgery at this time may have helped. Feedback from a consecutive 3-month sample of 17 patients treated on the IPU pathway (15 contactable) gave an average satisfaction score of 9.9 out of 10. No patients would have preferred treatment on the pre-COVID pathway, specifically quoting same-day, same-site Mohs surgery and reconstruction as a huge benefit. Table 1 Comparison of patient demographics, lesion characteristics, outcomes, and cost-savings between the former pre-COVID and IPU pathway for periocular skin cancer management. Full size table
ophthalmology
What problem does this paper attempt to address?